cobaltous chloride has been researched along with Hodgkin Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, R; Nakano, K; Nakashima, M; Uchimaru, K; Watanabe, M | 1 |
| Kewitz, S; Kurch, L; Staege, MS; Volkmer, I | 1 |
| FALZOI, M; GELATI, M | 1 |
3 other study(ies) available for cobaltous chloride and Hodgkin Disease
| Article | Year |
|---|---|
Differentiation of Hodgkin lymphoma cells by reactive oxygen species and regulation by heme oxygenase-1 through HIF-1α.
Topics: Cell Differentiation; Cell Hypoxia; Cell Line, Tumor; Cobalt; Gene Expression Regulation, Neoplastic; Heme Oxygenase-1; Hodgkin Disease; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1, alpha Subunit; Protoporphyrins; Reactive Oxygen Species | 2021 |
Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Cobalt; Drug Resistance, Neoplasm; Flow Cytometry; Hodgkin Disease; Humans; Hypoxia | 2016 |
[Antianemic effect of cobalt. I. Cobaltous chloride therapy in neoplastic anemia].
Topics: Anemia; Chlorides; Cobalt; Hodgkin Disease; Ions | 1952 |